Boston Scientific shares rise on U.S. approval for Parkinson ’s disease treatment

Boston Scientific Corp. announced U.S. regulators have approved its Vercise Deep Brain Stimulation System to treat patients with Parkinson ’s disease Monday, boosting its share price nearly 3 percent in after-hours trading. The device, which stimulates a specific area of the brain using implanted leads, was shown in a U.S. trial to help improve the number of waking hours per day in patients with the disease, according to the company . In another study in Europe, it helped patients achieve a 63 percent…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news